Search clinical trials for: Influenza vaccination

Total 1740 results

Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

Influenza Immunization

Puerto Rico, United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

Influenza

United States
Zealand University Hospital
University of Copenhagen

Completed

Intratumoral Influenza Vaccine for Early Colorectal Cancer

Colorectal Cancer

Denmark
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Seroprotection

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients

Influenza

United States
Rebecca Cox
Haukeland University Hospital; European Commission

Completed

Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults (PANFLUVAC)

Healthy | Influenza

Norway
Makerere University

Unknown

Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial (PREST)

Preventing Stroke in Sickle Cell Anaemia

Uganda
Rockefeller University

Terminated

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

Metabolic Syndrome | Immune Deficiency

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
Vanderbilt University
Centers for Disease Control and Prevention; Marshfield Clinic Research Foundation

Completed

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

Aging
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Federico Martinón Torres

Recruiting

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Influenza

Spain
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Bone Marrow and Peripheral Blood Immune Responses Study

Influenza

United States
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Stony Brook University
University of North Carolina, Chapel Hill

Completed

Flu Vaccine Response in Patients on Biologic Therapies

Inflammatory Bowel Diseases | Immune Complex Diseases | Rheumatologic Disorder

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - T Cells

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Antibody

Influenza

United States
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research (GFID)

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
University of Wisconsin, Madison

Completed

Immunological Consequences of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Fundación Pública Andaluza Progreso y Salud
Spanish Network for Research in Infectious Diseases

Completed

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination (TraNsgripe)

Infection in Solid Organ Transplant Recipients

Spain
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease

Italy
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Patients With Scleroderma

Influenza Vaccine in Scleroderma

Israel
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Queen Saovabha Memorial Institute

Recruiting

Immunological Tolerance After Frequent Rabies Booster Vaccinations

Rabies

Thailand
Selcuk University

Active, not recruiting

The Effectiveness of a Lung Health Promotion Program Based on the 5A Self Management Support Model.

Pulmonary Disease

Turkey
Syracuse University
Bill and Melinda Gates Foundation; Texas A&M University; Jimma University

Completed

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

Infant ALL

Ethiopia, United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Dutch...

Completed

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT (PSCT19)

Hematological Malignancies

Netherlands
Johns Hopkins University
Merck Sharp & Dohme LLC

Completed

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Chronic Kidney Disease

United States
Duke University

Terminated

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Metastatic Melanoma

United States
Seqirus
Novartis Vaccines

Completed

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Influenza Virus

United States, Canada, Finland, Italy, Mexico, Philippines, Poland, Puerto Rico, Spain, Taiwan, Thailand
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)

Influenza

Germany, Spain, United States, Korea, Republic of, Romania, Taiwan
Pfizer

Completed

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

Influenza, Human

United States, Brazil, South Africa, Philippines, New Zealand, Chile, Argentina
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

Influenza

United States, Germany, Philippines, Czechia, France
US Department of Veterans Affairs
St. Louis University

Withdrawn

MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly (CCTA #0005)

Aged | Influenza Vaccines

United States
Center for Disease Prevention and Control of Beijing...

Completed

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

Influenza

China
MedImmune LLC

Completed

A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children

Healthy

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Influenza

United States
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

Influenza

Germany
University of Toronto
International Care Ministries, the Philippines

Recruiting

A Tool Kit to Improve Vaccine Confidence in the Philippines

Measles | Polio | Vaccination Hesitancy

Philippines
Bandim Health Project
University of Southern Denmark

Recruiting

Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality? (CS-BCG)

Infant Mortality | BCG

Guinea-Bissau
Centre Hospitalier Universitaire de Nīmes

Active, not recruiting

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives. (VACTICOV2)

CORONAVIRUS INFECTIONS

France
Institut Pasteur
Institut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences and other collaborators

Completed

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule (NEOVAC2BK)

Hepatitis B

Burkina Faso
Changchun BCHT Biotechnology Co.
He Bei province Center for Disease control and prevention

Not yet recruiting

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Influenza Prevention

China
Xavier University of Louisiana.

Recruiting

TeleHealth Model to Address Vaccine Hesitancy & Increase Vaccine Completion Among Communities in Southeastern Louisiana

Vaccine Hesitancy

United States
Health Institutes of Turkey
TC Erciyes University; Mene Research; Kocak Farma

Not yet recruiting

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

Covid19

Turkey
Centre National de la Recherche Scientifique, France
Université Paris-Dauphine; Fondation La main à la pâte; Direction de l Évaluation...

Completed

Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents (Kidivax)

Health Knowledge, Attitudes, Practice | Vaccine Hesitancy | Vaccine Refusal

France
Clinton Health Access Initiative Inc.
Bill and Melinda Gates Foundation; Cameroon Expanded Program on Immunization

Completed

Cameroon HepB Birth Dose Feasibility Pilot

Hepatitis B

Cameroon
Fluart Innovative Vaccine Ltd, Hungary

Completed

Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

Influenza Prophylaxis

Hungary

Search clinical trials for: Influenza vaccination

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations